Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma
Not available.
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Ferrata Storti Foundation
2025-01-01
|
| Series: | Haematologica |
| Online Access: | https://haematologica.org/article/view/11907 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832590408753872896 |
|---|---|
| author | Julia Wendler Richard I. Lewis Alexandra Kutilina Markus Knott Lisa Kristina Isbell Elke Valk Peter Borchmann Jan-Michel Heger Gerald Illerhaus Elisabeth Schorb |
| author_facet | Julia Wendler Richard I. Lewis Alexandra Kutilina Markus Knott Lisa Kristina Isbell Elke Valk Peter Borchmann Jan-Michel Heger Gerald Illerhaus Elisabeth Schorb |
| author_sort | Julia Wendler |
| collection | DOAJ |
| description |
Not available.
|
| format | Article |
| id | doaj-art-98fbd8d3302e4b0f91f06d9ab736c295 |
| institution | Kabale University |
| issn | 0390-6078 1592-8721 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Ferrata Storti Foundation |
| record_format | Article |
| series | Haematologica |
| spelling | doaj-art-98fbd8d3302e4b0f91f06d9ab736c2952025-01-23T19:44:22ZengFerrata Storti FoundationHaematologica0390-60781592-87212025-01-01999110.3324/haematol.2024.286347Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphomaJulia Wendler0Richard I. Lewis1Alexandra Kutilina2Markus Knott3Lisa Kristina Isbell4Elke Valk5Peter Borchmann6Jan-Michel Heger7Gerald Illerhaus8Elisabeth Schorb9Clinic of Hematology, Oncology, Stem Cell Transplantation and Palliative Care, Klinikum Stuttgart, StuttgartDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany; Cologne Lymphoma Working Group (CLWG), CologneDepartment of Medicine I, Medical Center, Faculty of Medicine, University of FreiburgClinic of Hematology, Oncology, Stem Cell Transplantation and Palliative Care, Klinikum Stuttgart, StuttgartDepartment of Medicine I, Medical Center, Faculty of Medicine, University of FreiburgStuttgart Cancer Center – Tumorzentrum Eva Mayr-Stihl, StuttgartDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany; Cologne Lymphoma Working Group (CLWG), CologneDepartment I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Medical Faculty and University Hospital Cologne, Cologne, Germany; Cologne Lymphoma Working Group (CLWG), Cologne, Germany; Mildred Scheel School of Oncology Aachen Bonn Cologne Düsseldorf (MSSO ABCD), Cologne, Faculty of Medicine and University Hospital of Cologne, D-50937, CologneClinic of Hematology, Oncology, Stem Cell Transplantation and Palliative Care, Klinikum Stuttgart, StuttgartDepartment of Medicine I, Medical Center, Faculty of Medicine, University of Freiburg Not available. https://haematologica.org/article/view/11907 |
| spellingShingle | Julia Wendler Richard I. Lewis Alexandra Kutilina Markus Knott Lisa Kristina Isbell Elke Valk Peter Borchmann Jan-Michel Heger Gerald Illerhaus Elisabeth Schorb Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma Haematologica |
| title | Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma |
| title_full | Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma |
| title_fullStr | Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma |
| title_full_unstemmed | Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma |
| title_short | Pre-phase treatment with rituximab and high-dose methotrexate to re-evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma |
| title_sort | pre phase treatment with rituximab and high dose methotrexate to re evaluate eligibility for intensive induction treatment of frail patients with central nervous system lymphoma |
| url | https://haematologica.org/article/view/11907 |
| work_keys_str_mv | AT juliawendler prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT richardilewis prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT alexandrakutilina prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT markusknott prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT lisakristinaisbell prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT elkevalk prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT peterborchmann prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT janmichelheger prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT geraldillerhaus prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma AT elisabethschorb prephasetreatmentwithrituximabandhighdosemethotrexatetoreevaluateeligibilityforintensiveinductiontreatmentoffrailpatientswithcentralnervoussystemlymphoma |